电针“肘灵”,阿是穴配合刺络拔罐治疗肱骨外上髁炎30例临床观察

来源 :世界针灸杂志(英文版) | 被引量 : 0次 | 上传用户:lwh020827
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: To observe the clinical effect of electroacupuncture(EA) at Zhǒulíng (Extra) and Ashi points in combination with blood-letting cupping for the treatment of external humeral epicondylitis (EHE).Methods: Thirty EHE patients were treated with EA at Zhǒulíng (Extra) and Ashi points in combination with blood-letting cupping,once every 2 days,twice a week,4 times as one course of treatment,and 2 successive courses of treatment were given.Before treatment,after 1 course of treatment,and after 2 courses of treatment,the visual analogue scale (VAS) score and Mayo elbow performance score (MEPS)were adopted to evaluate the curative effect.Results: Before treatment,the VAS score of patients was 7.81±1.39.After 1 course of treatment and after 2 courses of treatment,it was 4.77±1.56 and 2.95±1.23 respectively,lowered than before treatment,and the difference was statistically significant (both P<0.01).Before treatment,the Mayo score of patients was 32.17±19.31.After 1 course of treatment and after 2 courses of treatment,it was 47.39±19.85 and 85.21±20.47 respectively,increased than before treatment,and the difference was statistically significant (both P<0.01),Of the 30 patients,5 were cured,accounting for 16.67%;14 cases obviously effective,accounting for 46.67%;8 cases effective,accounting for 26.67%;3 cases ineffective,accounting for 10.00%,and the total effective rate was 90.00%.Conclusion: EA at Zhǒulíng (Extra) and Ashi points and blood-letting cupping used in combination are remarkably effective in the treatment of EHE,being worthy for popularization.
其他文献
Objective: To observe the influence of wrist-ankle acupuncture (WAA) on postoperative nausea and vomiting (PONV) undergoing radiofrequency ablation (RFA) in thy
目的 研究益气解毒中药复方对2 Gy 60Coγ射线致小鼠急性辐射损伤的整体防护效应.方法 将30只雄性Bal b/c小鼠随机分为空白组、模型组和中药组,空白组和模型组灌胃去离子水,
乳腺癌占所有女性肿瘤的25%,是女性一种常见的恶性肿瘤,已成为女性死亡的主要原因[1]。乳腺癌的发生经历了以下几个阶段:正常-普通导管增生-不典型增生-导管原位癌-乳腺浸润性导
老药由于其药物代谢动力学特点为已知数据,其安全性也能得到保障,新用途的开发能很快进行Ⅱ期临床评估,老药新用目前成为新药研发的最有成果的一种方式。SENP1被报道在前列腺癌
请下载后查看,本文暂不支持在线获取查看简介。 Please download to view, this article does not support online access to view profile.